Boosting Medical Innovation
Leading medical device companies push innovation to the limit, fueled by the demand for new and cheaper medical solutions, an aging population and growing access to care.
On one end, small enhancements cannot deliver the sustainable competitive advantage that comes with disruptive innovations. And any innovation must be at least as reliable as the existing solution.
On the other end, time to market plays a key role that includes decreased costs. Accelerating product development from concept to release requires compressing the time for every stage of the process, including bench experiments, (pre-) clinical testing and FDA approval.
Pioneering healthcare companies virtually test all promising concepts in a virtual human laboratory, which uses a multiphysics computer-based model to subject a prototype to real-world conditions.
Designers can extensively validate promising prototypes by employing in silico testing before engaging in physical testing, a process that can speed up FDA approval.